New study tracks COPD patients on trimbow: better breathing or just better compliance?
NCT ID NCT03963167
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study followed 661 Italian adults with moderate to severe COPD who were prescribed the Trimbow inhaler. Researchers measured changes in health status using the COPD Assessment Test (CAT) and how well patients stuck to their medication over 12 months. The goal was to see if the treatment improves daily life and adherence in real-world settings.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for COPD are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Fondazione Policlinico Gemelli
Rome, Italy
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- A handheld device that vibrates the airways may help COPD patients breathe easier
- Can scientists unlock the secrets of breathing muscle failure in severe COPD?
- Which exercise is better for the COPD brain? scientists compare steady vs. burst workouts
- Your voice could hold the key to spotting lung disease
- Blood tests could unlock early clues for three major lung diseases
- Could a 7-Day antibiotic course be as effective as 14 days for COPD attacks?